Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Aridis Pharmaceuticals
AddedFeb 19, 2024
UpdatedJun 18, 2026
Aridis Pharmaceuticals

Aridis Pharmaceuticals

Public

Aridis Pharmaceuticals: A US-based biopharmaceutical firm innovating therapies for infectious diseases and antibody discovery.

HQ
San Jose, CA, US
Founded
1995
Overview
Compare
Fundraising
Employees
Website

Aridis Pharmaceuticals, Inc. is a biopharmaceutical company based in San Jose, United States, dedicated to developing novel therapies for infectious diseases. The company focuses on creating first-in-class anti-infectives for life-threatening viral and bacterial respiratory infections. Their innovative platform technology enables the discovery of rare, potent human monoclonal antibodies from patients, addressing global health threats such as antibiotic resistance and viral pandemics.

Aridis Pharmaceuticals has achieved significant milestones, including advancing their treatments for cystic fibrosis and pneumonia to phase 2a clinical trials. Their pioneering work in mining the human immune response for monoclonal antibodies has positioned them as leaders in combating infectious diseases. The company's impact is underscored by its commitment to addressing urgent medical needs with transformative therapies.

Aridis Pharmaceuticals - Similar Companies

Idbiologics logo

Idbiologics

idbiologics.com

Aria Pharmaceuticals logo

Aria Pharmaceuticals

Arisan Therapeutics logo

Arisan Therapeutics

arisanthera.com

Cidara Therapeutics logo

Cidara Therapeutics

cidara.com

Recida Therapeutics logo

Recida Therapeutics

Adrx logo

Adrx

adrxpharma.com

Adarx Pharmaceuticals logo

Adarx Pharmaceuticals

adarx.com

Adimab logo

Adimab

adimab.com

Recreo Pharmaceuticals logo

Recreo Pharmaceuticals

recreopharm.com

Arisaph Pharmaceuticals logo

Arisaph Pharmaceuticals

ArrePath logo

ArrePath

arrepath.com

Argentis Pharmaceuticals logo

Argentis Pharmaceuticals

argentisrx.com

Ardelyx logo

Ardelyx

ardelyx.com

Armata Pharmaceuticals logo

Armata Pharmaceuticals

armatapharma.com

Taxis Pharmaceuticals logo

Taxis Pharmaceuticals

taxispharma.com

Aridis Pharmaceuticals - Quick Facts

Who are Aridis Pharmaceuticals' competitors?

Companies similar to Aridis Pharmaceuticals include Idbiologics, Aria Pharmaceuticals, Arisan Therapeutics and Cidara Therapeutics.

When was Aridis Pharmaceuticals founded?

Aridis Pharmaceuticals was founded in 1995.

Where is Aridis Pharmaceuticals' headquarters located?

Aridis Pharmaceuticals' headquarters is located in San Jose, CA, US.

When was Aridis Pharmaceuticals' last funding round?

Aridis Pharmaceuticals' most recent funding round was for $2.3M (USD) in March 2023.

How much has Aridis Pharmaceuticals raised to-date?

As of Mar 14, 2023, Aridis Pharmaceuticals has raised a total of $81.7M (USD).

How many employees does Aridis Pharmaceuticals have?

Aridis Pharmaceuticals has 37 employees as of Feb 6, 2024.

Aridis Pharmaceuticals - Classification

Ownership
  • Public
Technology
  • Biotech
Geographic Exposure
  • United States
Revenue
  • Recurring
Customer
  • Enterprise
Main Product
  • Antibody Therapies
  • Pharmaceuticals
Tags
  • Healthtech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 2800Chemicals And Allied Products
  • 2830Drugs
  • 2834Pharmaceutical Preparations
ISIC
  • 2100Manufacture of pharmaceuticals, medicinal chemical and botanical products
Show 14 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 623000Nursing and Residential Care Facilities
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 4000Railroad Transportation
  • 8000Health Services
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8730Research, Development, And Testing Services
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
  • 8731Commercial Physical and Biological Research